Low-dose rituximab for the treatment of acute thrombotic thrombocytopenic purpura: Report of four cases

By Peque駉-Lu関ano Myrna   Villarreal-Mart韓ez Laura   Jaime-P閞ez Jos?Carlos   G髆ez-de-Le髇 Andr閟   Cant?Rodr韌uez Olga Graciela   Gonz醠ez-Llano Oscar   G髆ez-Almaguer David  

Hematology, Vol. 18, Iss. 4, 2013-07 ,pp. : 233-236

Maney Publishing

Access to resources Recommend Favorite

Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab

By Schweizer Christof   Reu Frederic   Ho Anthony   Hensel Manfred  

Annals of Hematology, Vol. 86, Iss. 10, 2007-10 ,pp. : 711-717

Springer Publishing Company

Access to resources Recommend Favorite

Low-dose and rapid steroid withdrawal in renal transplant patients treated with tacrolimus and mycophenolate mofetil

By Sola E.   Alferez M.J.   Cabello M.   Burgos D.   Gonzalez Molina M.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1689-1690

Elsevier

Access to resources Recommend Favorite

Rituximab Therapy for Refractory Thrombotic Thrombocytopenic Purpura

By Gutterman L.A.   Kloster B.   Tsai H-M.  

Blood Cells, Molecules, and Diseases, Vol. 28, Iss. 3, 2002-03 ,pp. : 385-391

Academic Press

Access to resources Recommend Favorite

Induction treatment with mycophenolate mofetil, cyclosporine, and low-dose steroids with subsequent early withdrawal in renal transplant patients: results of the Spanish group

By Puig i Mar J.M.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2256-2258

Elsevier

Access to resources Recommend Favorite